Cresco Labs (updated as of January 2020)

CSE: CL // OTC: CRLBF

// investor presentation

// Cresco Labs & Tryke investor presentation

note: share unlock information

note: pro-forma shares (Origin House, Tryke)

 

Structure -

 

fully diluted share count: 409,052,190‬

market cap: $2,383,056,248

Financials (Q3) -

last q reported revenue: $36,207,xxx

last q pro-forma revenue: $73.6M

last q adj. ebitda: $11,090,xxx

last q total assets: $416,526,xxx

last q cash: $73,658,xxx

last q total liabilities: $101,275,xxx

last q net loss: $8,594,xxx

last q gross margin: 35%

Licenses -

  • 10 states

  • 22/30 operational retail locations

  • 17/21 operational production facilities

Arizona

operational: retail (3), cultivation (3)

total: retail (3), cultivation (3)

California

operational: retail (0), cultivation (5)

total: retail (0), cultivation (5)

note: California exposure with proposed Origin House acquisition

Illinois

operational: retail (5), cultivation (3)

total: retail (8), cultivation (3)

note: co-located adult-use/medical dispensaries (all 5 stores) & cultivation (all 3 facilities)

note: company can open an additional 3 adult-use dispensaries (Central Chicago [x2], South East Chicago)

Massachusetts

operational: retail (1), cultivation (1)

total: retail (3), cultivation (1)

note: co-located adult-use/medical dispensary & production (Fall River)

Michigan

operational: retail (0), cultivation (0)

total: retail (0), cultivation (1)

note: pre-qualified for cultivation/processing license

Nevada

operational: retail (5), cultivation (2)

total: retail (5), cultivation (3)

New York

operational: retail (4), cultivation (0)

total: retail (4), cultivation (1)

Ohio

operational: retail (1), cultivation (1)

total: retail (1), cultivation (1)

Pennsylvania

operational: retail (3), cultivation (1)

total: retail (6), cultivation (1)

Utah

operational: retail (0), cultivation (0)

total: retail (0), cultivation (1)

Footprint Map -

license

cultivation

dispensary

  • Black Twitter Icon